Zobrazeno 1 - 10
of 27
pro vyhledávání: '"M. Reid Groseclose"'
Autor:
Shih-Hsun Cheng, M. Reid Groseclose, Cindy Mininger, Mats Bergstrom, Lily Zhang, Stephen C. Lenhard, Tinamarie Skedzielewski, Zachary D. Kelley, Debra Comroe, Hyundae Hong, Haifeng Cui, Jennifer L. Hoover, Steve Rittenhouse, Stephen Castellino, Beat M. Jucker, Hasan Alsaid
Publikováno v:
Journal of Controlled Release. 352:199-210
Liposomes are promising targeted drug delivery systems with the potential to improve the efficacy and safety profile of certain classes of drugs. Though attractive, there are unique analytical challenges associated with the development of liposomal d
Autor:
Hasan Alsaid, Shih-Hsun Cheng, Meixia Bi, Fang Xie, Mary Rambo, Tinamarie Skedzielewski, Bao Hoang, Sunish Mohanan, Debra Comroe, Andrew Gehman, Chih-Yang Hsu, Kamyar Farhangi, Hoang Tran, Valeriia Sherina, Minh Doan, M. Reid Groseclose, Christopher B. Hopson, Sara Brett, Ian A. Wilson, Andrew Nicholls, Marc Ballas, Jeremy D. Waight, Beat M. Jucker
Publikováno v:
Molecular Imaging and Biology. 25:528-540
Purpose The presence and functional competence of intratumoral CD8+ T cells is often a barometer for successful immunotherapeutic responses in cancer. Despite this understanding and the extensive number of clinical-stage immunotherapies focused on po
Autor:
Carlos L. Arteaga, Christos Sotiriou, Martine Piccart, José Baselga, David Brown, David Venet, Sylvain Brohée, Samira Majjaj, Jan C. Brase, Jens Huober, Heikki Joensuu, Stephen Castellino, M. Reid Groseclose, Jennifer Becker, Philip Owens, Eric Sanford, Garrett M. Frampton, Phillip S. Kim, Sharat Singh, Emma Langley, James P. Koch, Paula González Ericsson, Preston D. Moore, Mónica Valeria Estrada, Joan T. Garrett, Ariella B. Hanker
Table S1. Deep sequencing of ERBB2 does not identify recurrent ERBB2 mutations in LTR tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4a52cd6b60a7b877f482c38af9b70cd
https://doi.org/10.1158/1078-0432.22468419
https://doi.org/10.1158/1078-0432.22468419
Autor:
Carlos L. Arteaga, Christos Sotiriou, Martine Piccart, José Baselga, David Brown, David Venet, Sylvain Brohée, Samira Majjaj, Jan C. Brase, Jens Huober, Heikki Joensuu, Stephen Castellino, M. Reid Groseclose, Jennifer Becker, Philip Owens, Eric Sanford, Garrett M. Frampton, Phillip S. Kim, Sharat Singh, Emma Langley, James P. Koch, Paula González Ericsson, Preston D. Moore, Mónica Valeria Estrada, Joan T. Garrett, Ariella B. Hanker
Supplementary Methods and Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7994a6c8a70f40f1144856986ab07fa8
https://doi.org/10.1158/1078-0432.22468422.v1
https://doi.org/10.1158/1078-0432.22468422.v1
Autor:
Carlos L. Arteaga, Christos Sotiriou, Martine Piccart, José Baselga, David Brown, David Venet, Sylvain Brohée, Samira Majjaj, Jan C. Brase, Jens Huober, Heikki Joensuu, Stephen Castellino, M. Reid Groseclose, Jennifer Becker, Philip Owens, Eric Sanford, Garrett M. Frampton, Phillip S. Kim, Sharat Singh, Emma Langley, James P. Koch, Paula González Ericsson, Preston D. Moore, Mónica Valeria Estrada, Joan T. Garrett, Ariella B. Hanker
Purpose: Dual blockade of HER2 with trastuzumab and lapatinib or pertuzumab has been shown to be superior to single-agent trastuzumab. However, a significant fraction of HER2-overexpressing (HER2+) breast cancers escape from these drug combinations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49174e1dbcff7c745ca57a9a1ba1a5b9
https://doi.org/10.1158/1078-0432.c.6526929
https://doi.org/10.1158/1078-0432.c.6526929
Autor:
Hasan, Alsaid, Shih-Hsun, Cheng, Meixia, Bi, Fang, Xie, Mary, Rambo, Tinamarie, Skedzielewski, Bao, Hoang, Sunish, Mohanan, Debra, Comroe, Andrew, Gehman, Chih-Yang, Hsu, Kamyar, Farhangi, Hoang, Tran, Valeriia, Sherina, Minh, Doan, M Reid, Groseclose, Christopher B, Hopson, Sara, Brett, Ian A, Wilson, Andrew, Nicholls, Marc, Ballas, Jeremy D, Waight, Beat M, Jucker
Publikováno v:
Molecular imaging and biology.
The presence and functional competence of intratumoral CD8Female BALB/c mice with established EMT6 tumors received 10 µg, IP of either IgG control antibodies, ICOS agonist monotherapy, or ICOS/PD-1 combination therapy on days 0, 3, 5, 7, 9, 10, or 1
Autor:
Eric Solon, M. Reid Groseclose, Stacy Ho, Kouji Tanaka, Naoyuki Nakada, Stefan Linehan, Masanobu Nishidate, Hiroyuki Yokoi, Hidefumi Kaji, Yoko Urasaki, Kenichi Watanabe, Tomomi Ishida, Rika Komatsu, Kenji Yoshida, Hiroshi Yamazaki, Kosuke Saito, Yoshiro Saito, Yukari Tanaka
Publikováno v:
Drug metabolism and pharmacokinetics. 43
Imaging mass spectrometry (IMS) is increasingly used for drug discovery and development to understand target enagement, tissue distribution, drug toxicity, and disease mechanisms, etc. However, this is still a relatively new technique that requires f
Autor:
Stephen Castellino, M. Reid Groseclose
Publikováno v:
International Journal of Mass Spectrometry. 437:92-98
Recently, researchers have begun exploring the use of injectable long-acting antiretroviral drug formulations that could improve treatment adherence by offering HIV patients infrequent dosing regimens (≥monthly), which is an attractive alternative
Publikováno v:
Current Opinion in Biotechnology. 55:51-59
Matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) has emerged as a key technology for label-free bioanalysis of the spatial distribution of biomolecules, pharmaceuticals and other xenobiotics in tissue sections. Recent
Publikováno v:
MALDI Mass Spectrometry Imaging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8aa813f0d9ea5027ade318d0f5bb2eb8
https://doi.org/10.1039/9781839165191-00321
https://doi.org/10.1039/9781839165191-00321